Cogent Biosciences, Inc.
NASDAQ:COGT
7.14 (USD) • At close March 14, 2025
Overview | Financials
Cijfers zijn in miljoenen (behalve de cijfers per aandeel en de ratio's) USD.
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operationele Activiteiten: | ||||||||||
| Nettowinst
| 0 | -192.41 | -140.241 | -72.273 | -74.808 | -31.833 | -34.532 | -25.492 | -18.124 | -6.592 |
| Afschrijvingen & Amortisatie
| 0 | 3.588 | 5.878 | 0.147 | 0.72 | 1.293 | 1.321 | 1.171 | 0.83 | 0.179 |
| Uitgestelde Inkomstenbelasting
| 0 | 0 | 0 | 0 | -7.493 | 0 | -0.236 | 0.017 | 0.017 | -0.248 |
| Aandelen Gebaseerde Vergoedingen
| 0 | 30.621 | 18.368 | 11.686 | 6.017 | 3.241 | 3.088 | 1.341 | 1.016 | 0.248 |
| Verandering in Werkkapitaal
| 0 | 11.442 | 0.751 | 2.02 | -5.316 | -14.084 | -2.153 | -2.879 | -2.323 | 23.881 |
| Vorderingen
| 0 | 0 | 0 | 0 | 2 | -0.332 | -0.838 | 0.098 | -0.634 | -0.294 |
| Voorraden
| 0 | 0 | 0 | 0 | -3.55 | 1.218 | 2.214 | 0.931 | 0.784 | 0.22 |
| Crediteuren
| 1.358 | 4.813 | 2.359 | 2.751 | -2.451 | 1.664 | 0.367 | -0.031 | 0.389 | 0.705 |
| Overig Werkkapitaal
| 10.238 | 6.629 | -1.608 | -0.731 | -1.315 | -16.634 | -3.896 | -3.877 | -2.862 | 23.25 |
| Overige Niet-Contante Posten
| -207.791 | -6.865 | -3.394 | -0.343 | 45.03 | -0.131 | 0.023 | 0.007 | -0.056 | 0.248 |
| Kasstroom uit Operationele Activiteiten
| -207.791 | -153.624 | -118.638 | -58.763 | -35.85 | -41.514 | -32.489 | -25.835 | -18.64 | 17.716 |
| Investeringsactiviteiten: | ||||||||||
| Investeringen in Materiële Vaste Activa
| 0 | -2.796 | -6.863 | -1.719 | 0 | -0.033 | -0.549 | -0.912 | -3.307 | -1.994 |
| Netto Overnames
| 0 | 0 | 0.118 | 0 | 8.42 | 0.204 | 0 | 0 | 0 | 0 |
| Aankoop van Beleggingen
| 0 | -348.803 | -177.855 | 0 | 0 | -0.204 | -47.682 | -6.5 | -55.172 | 0 |
| Verkoop/verval van Beleggingen
| 0 | 253.775 | 60 | 0 | 0 | 22.988 | 37.7 | 21 | 28 | 0 |
| Overige Investeringsactiviteiten
| 38.276 | 0 | -0.118 | 0 | 0.008 | 0.204 | 0 | -0.075 | 0.05 | -1.255 |
| Kasstroom uit Investeringsactiviteiten
| 38.276 | -97.824 | -124.718 | -1.719 | 8.42 | 23.159 | -10.531 | 13.513 | -30.429 | -3.249 |
| Financieringsactiviteiten: | ||||||||||
| Schuldaflossingen
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Uitgifte van Gewone Aandelen
| 213.336 | 161.819 | 161.945 | 38.006 | 132.729 | 0.108 | 71.793 | 0.06 | 0 | 70.752 |
| Terugkoop van Gewone Aandelen
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Uitgekeerde Dividenden
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Overige Financieringsactiviteiten
| 1.115 | 1.717 | 1.613 | -0.03 | 99.467 | 0.108 | -1.447 | -0.789 | -0.04 | 70.752 |
| Kasstroom uit Financieringsactiviteiten
| 214.451 | 163.536 | 163.558 | 37.976 | 232.196 | 0.108 | 70.346 | -0.729 | -0.04 | 70.752 |
| Overige Informatie: | ||||||||||
| Effect van Wisselkoersveranderingen op Kas
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Netto Kasstroomverandering
| 44.936 | -87.912 | -79.798 | -22.506 | 204.766 | -18.247 | 27.326 | -13.051 | -49.109 | 85.219 |
| Kaspositie aan het Einde van de Periode
| 98.165 | 53.229 | 141.141 | 220.939 | 243.445 | 38.679 | 56.926 | 28.27 | 41.321 | 90.43 |